Collagenase clostridium histolyticum [EC:3.4.24.3] is bacterial enzymes produced the Clostridium histolyticum.
Treatment of Dupuytren's disease
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M09 OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09A OTHER DRUGS FOR DISORDERS OF THE MUSCULO-SKELETAL SYSTEM
M09AB Enzymes
M09AB02 Collagenase clostridium histolyticum
D09596 Collagenase clostridium histolyticum (USAN) <JP/US>
USP drug classification [BR:br08302]
Dermatological Agents
Dermatological Agents, Other
Dermatological Agents, Miscellaneous
Collagenase Clostridium Histolyticum
D09596 Collagenase clostridium histolyticum (USAN)
Wound Care Agents
Collagenase
D09596 Collagenase clostridium histolyticum (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
29 Other agents affecting individual organs
290 Other agents affecting individual organs
2900 Other agents affecting individual organs
D09596 Collagenase clostridium histolyticum (USAN); Collagenase (Clostridium histolyticum) (JAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09596
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09596
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09596
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09596
